ClinicalTrials.Veeva

Menu

Evaluation of the Long Term Efficacy of Endovascular Treatment of Type 2 Endoleaks

U

University Hospital Center (CHU) Dijon Bourgogne

Status

Completed

Conditions

Abdominal Aortic Aneurysm

Treatments

Procedure: Type II endoleak treatment

Study type

Observational

Funder types

Other

Identifiers

NCT04409717
CCVT - type 2 endoleaks

Details and patient eligibility

About

Endovascular treatment has become the first choice to repair abdominal aortic aneurym, but exposes patients to a risk of endoleaks. Although treatment of type 1 and 3 endoleaks has proven to prevent aneurysms from rupture, controversies remain about type 2 endoleaks. The investigators described the different techniques of type 2 endovascular repair, and their efficacy at short and long term..

Enrollment

19 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients treated for type II endoleaks by endovascular therapy

Exclusion criteria

  • None

Trial design

19 participants in 1 patient group

Patients treated for type II endoleaks
Description:
Patients treated for type II endoleaks between the 01 January 2008 and the 31 March 2018 in the Cardiovascular and Thoracic Surgery Unit of Dijon Burgundy University Hospital
Treatment:
Procedure: Type II endoleak treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems